Additional support came from Abingworth, Invus, Tenmile, Vida Ventures, Vinyanshu Ventures and Willett Advisors.

Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...

The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9.

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

On the evening of June 9, skywatchers will be treated to a beautiful cosmic pairing. The waxing gibbous moon will glow close ...

The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...

Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...

The rest of Scorpion’s assets were to be spun out into a new company. That startup, Boston-based Antares Therapeutics, launched Tuesday. Scorpion was founded in 2020 by serial biotech ...

Ares Management is backing the continuation fund, an increasingly popular tool for private-credit managers to return cash to ...

The global Track and Trace Solutions Market, valued at US$6.20 billion in 2024 stood at US$6.96 billion in 2025 and is ...

Don't miss tonight's view of the rare strawberry moon as it rises next to 'heart of the Scorpion' star, Antares.

Antares Capital and Ares Management Corporation ("Ares") (NYSE: ARES) today announced the closing of Antares’ first continuation vehicle with over $1.2 billion in commitments. The transaction was led ...